CAS 829-74-3: Levonordefrin
Formula:C9H13NO3
InChI:InChI=1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3/t5-,9-/m0/s1
InChI key:InChIKey=GEFQWZLICWMTKF-CDUCUWFYSA-N
SMILES:[C@@H]([C@H](C)N)(O)C1=CC(O)=C(O)C=C1
Synonyms:- (-)-3,4-Dihydroxynorephredrine
- (-)-Cobefrin
- (-)-Nordefrin
- (-)-erythro-α-Methylnoradrenaline
- (-)-α-Methylnoradrenaline
- (1R,2S)-(-)-3,4-Dihydroxynorephedrine
- (?-3,4-Dihydroxynorephedrine
- 1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)-, [R-(R*,S*)]-
- 1,2-Benzenediol, 4-[(1R,2S)-2-amino-1-hydroxypropyl]-
- 4-[(1R)-2-amino-1-hydroxypropyl]benzene-1,2-diol
- 4-[(1R,2S)-2-Amino-1-hydroxypropyl]-1,2-benzenediol
- See more synonyms
Sort by
Found 4 products.
Levonordefrin
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C9H13NO3Color and Shape:Grey Beige PowderMolecular weight:183.08954(-)-3,4-Dihydroxy norephedrine
CAS:Controlled Product(-)-3,4-Dihydroxy norephedrine is a pharmaceutical drug that belongs to the group of adrenergic receptor agonists. It is used in the treatment of infectious diseases, such as osteoclast formation, and has been shown to inhibit the proliferation of cancer cells. It also inhibits the enzyme fatty acid synthase and reduces levels of prostaglandin E2 (PGE2) in tumors. This drug is a prodrug that is hydrolyzed by esterases or glucuronidases to form (-)-3,4-dihydroxyphenylalanine (L-DOPA). L-DOPA is converted into dopamine by aromatic L-amino acid decarboxylase (AADC) and then into norepinephrine by dopamine β-hydroxylase. The second order rate constant for this reaction may be determined using ethylene diamine. Excipients are added to prevent adverse reactions from procaineFormula:C9H13NO3Purity:Min. 95%Molecular weight:183.2 g/mol(-)-3,4-Dihydroxynorephedrine
CAS:Formula:C9H13NO3Purity:98%Color and Shape:SolidMolecular weight:183.2044
